Diabetics missing out on statins

Written by Mohan Garikiparithi
Published on

Diabetics missing out on statinsMany diabetics should be taking cholesterol-lowering statins, and yet many of the patients are never prescribed this medication, although it could greatly help their condition. Numerous previous studies have pointed out that diabetics benefit from taking statins as the medication lowers their risk of heart disease and stroke.

The analysis of data from 204 cardiology practices unveiled that at least 38 percent of diabetics are never prescribed statins.

The American College of Cardiology, the American Heart Association, and the American Diabetes Association all recommend that anyone over the age of 40 with diabetes be prescribed statins.
Not only did the researchers find that so many diabetics are not being prescribed statins, but that prescriptions are randomly assigned. The researchers found a 57 percent variation in statin-prescribing practices, even after taking into account a person’s risk factors. For example, if you look at two patients who are identical but are seeing different cardiologists, there is a 57 percent chance that one of them will be prescribed statins over the other.

Although the study findings suggest there are not enough diabetics receiving life-saving statins, it did reveal that more diabetics today are receiving statins than before. This upward trend shows that more lives may be saved and that these individuals will have a reduced risk of heart disease and stroke.


Advertisement

On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.

Exit mobile version